PMID: 48835May 31, 1975Paper

Modification by propranolol of cardiovascular effects of induced hypoglycaemia

Lancet
R H Lloyd-Mostyn, S Oram

Abstract

The cardiovascular effects of hypoglycaemia, with and without beta-blockade, were compared in fourteen healthy men. Eight received insulin alone, and eight, including two of the original insulin-only group, were given propranolol and insulin. In the insulin-group the period of hypoglycaemia was associated with an increase in heart-rate and a fall in diastolic blood-pressure. In the propranolol-insulin group there was a significant fall in heart-rate in most subjects and an increase in diastolic pressure. Typical S-T/T changes occurred in the insulin-group but in none of the propranolol-insulin group. Hypertension in diabetics prone to hypoglycaemia attacks should not be treated with beta-blockers because these drugs may cause a sharp rise in blood-pressure in such patients.

Citations

Dec 28, 1977·European Journal of Clinical Pharmacology·C L van HerwaardenA van't Laar
Jul 1, 1979·Canadian Anaesthetists' Society Journal·R MartinO R Moliner
Mar 23, 2013·Pediatric Surgery International·Qiang XiaoWenlin Yu
Jan 27, 1984·The American Journal of Cardiology·L G Lipson
Jan 1, 1983·Pharmacology & Therapeutics·A J Scriven, P J Lewis
Jan 1, 1983·Pharmacology & Therapeutics·M J Kendall, L Beeley
Jan 1, 1985·General Pharmacology·J I DrayerP P Frankfort
Sep 10, 2013·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·M de GraafS G M A Pasmans
Apr 30, 1977·Lancet·A G Cudworth, J C Woodrow
Nov 23, 1985·Lancet·B M Frier, J Hilsted
Sep 1, 1979·Paraplegia·C J MathiasN J Christensen
Dec 4, 1975·The New England Journal of Medicine
Dec 28, 1978·The New England Journal of Medicine·U Smith, I Lager
Nov 1, 1990·British Journal of Clinical Pharmacology·A J SinclairS J Warrington
Mar 1, 1991·Journal of Internal Medicine·T KjellströmF Lindgärde
Jul 1, 1992·Diabetic Medicine : a Journal of the British Diabetic Association·T LindströmH J Arnqvist
Jan 31, 2003·The Journal of Clinical Hypertension·Joel Handler
Sep 1, 1979·British Medical Journal·R H Lloyd-Mostyn, R M Goodfellow
Oct 25, 1980·British Medical Journal·U SmithP Lönnroth
Nov 17, 1984·British Medical Journal·L Beeley
Jul 1, 1985·Postgraduate Medical Journal·A D Struthers
Aug 1, 1988·Journal of Clinical Pharmacy and Therapeutics·H LewisJ R Bratty
Feb 28, 2001·Diabetes, Obesity & Metabolism·S R Heller, R T Robinson
Aug 14, 2002·Journal of Clinical Pharmacy and Therapeutics·M J LandrayM J Kendall
Apr 29, 1998·Japanese Circulation Journal·R MatsunagaY Omori
Oct 25, 1980·British Medical Journal·J S Crawford
Oct 25, 1980·British Medical Journal
Apr 23, 2008·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Tomi LaitinenMarkku Laakso
May 8, 2008·Diabetes/metabolism Research and Reviews·Rohana J Wright, Brian M Frier
Nov 22, 2007·Journal of Cardiovascular Pharmacology·Sara Del ColleFranco Veglio
Sep 20, 2005·The Journal of Small Animal Practice·C J L Little

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.